The MAN VAN® program, established in 2009, is Canada’s first—and Alberta’s only—mobile men’s health clinic. It offers free PSA (prostate-specific antigen) blood testing to detect early signs of prostate cancer in men aged 40 to 70 in Alberta, with no appointment necessary.
The MAN VAN® program is an innovative and vital initiative that has significantly impacted men’s health in Alberta. It stands as a testament to the importance of accessible and affordable healthcare services for everyone.
Festivus of Gravel
Celebrate the spirit of Festivus with a gravel cycling weekend festival hosted by Tour de France veteran, Alex Stieda and the Town of Thorsby, Alberta, Canada. Explore the stunning gravel terrain around Thorsby, Alberta, Canada across Leduc, Brazeau and Parkland counties. There's a challenging distance for everyone - 40km (NEW!), 55km, 105km, 190km, or 295km.
And the best part, we are now part of the Gravel Earth Series, a group of the best gravel events in the World!
We are also raising funds for a Northern Alberta MAN VAN®, a mobile prostate cancer testing vehicle.
The Prostate Cancer Centre (PCC), in partnership with the Southern Alberta Institute of Urology, is a charitable organization and world-class medical centre dedicated to the fight against prostate cancer. For more than 20 years, we’ve been advocating for equitable access to healthcare for all men across Alberta.
We offer one-stop support with comprehensive programs and services for patients and their families through every step of their journey – everything from education to blood testing for early prostate cancer detection to post-operative care and mental wellness support.
Our Programs and Services
Our MAN VAN® Canada’s first and only mobile men’s health clinic offering free PSA (prostate-specific antigen) blood testing for early prostate cancer detection in men in Alberta.
Visit a MAN VAN®
Our research department is recognized as one of the top facilities in Canada. We’re driving prostate cancer research forward while giving patients local access to participate in international clinical trials and cutting-edge treatments.